NIHR

R&D

Sponsored

Inside the NCVR evolution in the UK

For years, the UK's clinical research landscape held a frustrating truth: costing and contracting for commercial research needed to evolve if the nation was to remain an attractive option f

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

R&D

Sponsored

EDI in clinical research: The case for adaptive strategies a...

The topic of Equality, Diversity, and Inclusion (EDI) in health and care research participation has been gaining traction in the past few years.

Market Access

Sponsored

NCVR: What's the true price of negotiation?

A country’s ability to open trials quickly is a key consideration for commercial sponsors planning programmes of research globally.

Patients

From participants to partners - hand shake

From participants to partners: The evolution of active patie...

Recruitment numbers are the backbone of clinical research.

R&D

Sponsored

Revolutionising research: Inside the NCVR evolution in the U...

On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio

R&D

PART 2: Right research, right time, right place

Sponsored

Inside the NCVR evolution in the UK

EDI in clinical research: The case for adaptive strategies a...

NCVR: What's the true price of negotiation?

From participants to partners: The evolution of active patie...

Revolutionising research: Inside the NCVR evolution in the U...

An inside guide to unlocking clinical research in the UK

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

NIHR

Editor's Picks